Clinical Validation

In this independent study, investigators combined Cognitive Behavioral Therapy (CBT) with use of the Crescendo device in women diagnosed with Female Sexual Arousal Disorder (FSAD) for 12 weeks.

Findings reported in the paper:

• FSFI-Arousal domain: mean score increased from 1.22 to 2.11 (+73%).
• FSFI-Lubrication domain: mean score increased from 2.06 to 3.97 (+93%).
• No device-related adverse events were recorded.

Full methodology and results are available in the published article (LINK).

Investigators studied women experiencing situational anorgasmia (difficulty achieving orgasm during intercourse) for six weeks while they used the Crescendo 2 device at home.

Findings reported in the paper:

• FSFI-Orgasm domain: mean score increased from 1.62 to 3.47 (2-fold rise) .
• Orgasm-achievement rate: 90.47% at week 6.
• No device-related adverse events were recorded.

Full methodology and results are available in the published article (LINK).

Investigators evaluated the Legato device, which delivers focused mechanical vibration (FMV), in women who reported arousal and lubrication difficulties.

Findings reported in the paper:

• After eight weeks, mean FSFI-Arousal scores increased by 83%.
• Mean FSFI-Lubrication scores rose 4-fold.
• No device-related adverse events were recorded.

Full methodology and results are available in the published article (LINK).

Investigators documented eight weeks of home use of the Molto device by a patient diagnosed with vaginismus, a condition causing genital pain during penetration.

Findings reported in the paper:

• FSFI-Pain score increased from 0 to 4.8 on the 0–6 scale (5-fold rise) .
• No device-related adverse events were recorded.

Full methodology and results are available in the published article (LINK).

Investigators evaluated Tenuto 2, an on-demand focused-vibration device, in men diagnosed with psychogenic erectile dysfunction.

Findings reported in the paper:

• Mean IIEF-5 score increased 81% during an 8-week home-use protocol.
• No device-related adverse events were recorded.

Full methodology and results are available in the published article (LINK).

Investigators evaluated Tenuto 2, an on-demand focused-vibration device, in men experiencing erection difficulties after prostate-cancer radiotherapy.

Findings reported in the paper:

• Mean IIEF-5 score rose 2.3x (from 6 to 14) after 5 weeks of home use.
• No device-related adverse events were recorded.

Full methodology and results are available in the published article (LINK).

Investigators evaluated Tenuto 2, an on-demand focused-vibration device, in men undergoing penile-rehabilitation after radical prostatectomy.

Findings reported in the paper:

• Mean IIEF score increased from 11 (pre-treatment) to 19 after 6 months of home use.
• No device-related adverse events were recorded.

Full methodology and results are available in the published article (LINK).

Investigators evaluated Tenuto Mini, a wearable constriction-vibration device, in a man diagnosed with situational (non-organic) erectile dysfunction.

Findings reported in the paper:

• IIEF-5 score rose 2.7x from 6 (baseline) to 16 after a 2-month home-use protocol.
• No device-related adverse events were recorded.

Full methodology and results are available in the published article (LINK).

Investigators evaluated Tenuto Mini, a vibrating constriction ring with focused mechanical vibration, in men diagnosed with psychogenic erectile dysfunction.

Findings reported in the paper:

• Mean IIEF-5 score rose from 10.95 (baseline) to 19.56 after an 8-week home-use protocol (79% improvement).
• No device-related adverse events were recorded.

Full methodology and results are available in the published article (LINK).

Investigators evaluated Tenuto Mini, a vibrating constriction ring that delivers focused mechanical vibration, in 30 men (mean age 39) diagnosed with psychogenic erectile dysfunction.

Findings reported in the paper:

• Mean IIEF-5 score increased from 14.44 to 22.31 after an 8-week home-use protocol (55% improvement).
• Participants reported high treatment satisfaction (mean EDITS of 78%).
• No device-related adverse events were recorded.

Full methodology and results are available in the published article (LINK).

Investigators studied Molto, a slim, bendable vibration probe, in men with chronic non-bacterial prostatitis that was unresponsive to previous care. Questionnaires documented improvements in erectile function and overall sexual satisfaction.

Findings reported in the paper:

• Mean pain score (VAS) fell from 7/10 to 3/10 after 3 months of use.
• No device-related adverse effects were reported.

Full methodology and results are available in the published article (LINK).

Researchers assessed Molto as an insertable vibration aid for men experiencing delayed or anejaculation.

Findings reported in the paper:

• 45.5% of participants achieved ejaculation within ~4 weeks of use.
• Participants rated comfort and tolerability as good.
• No device-related adverse events were recorded.

Full methodology and results are available in the published article (LINK).

This independent review article surveyed a range of sexual-enhancement devices and their evidence-referenced roles in sexual-wellness practice. MV devices including Molto, Tenuto, Crescendo, and Legato were noted for enhancing sexual wellness and for the observational outcomes reported in peer-reviewed studies.

This highlights the growing interest in evidence-informed sexual wellness tools.(LINK)